Development Pipeline

Bayer HealthCare Pharmaceuticals concentrates its R&D activities on innovative treatment alternatives for diseases with a high unmet medical need to improve patients’ quality of life and prolong lives. The focus is on therapeutic areas with a high medical need, where more innovations are needed despite considerable progress.

Image: lab situation

Balanced mix of new substance developments and life cycle management opportunities

In this context, Bayer HealthCare Pharmaceuticals focuses on its core competencies and its many years of experience. We thus hold a leading position in many therapeutic fields: for instance in the treatment of hemophilia and multiple sclerosis, in contrast media and oral contraception. We are also striving for such a leading position in oncology. With new approaches in cancer therapy, cardiovascular diseases and gynaecological therapies Bayer HealthCare Pharmaceuticals seeks to become an innovation leader in these fields.

In addition, Bayer HealthCare Pharmaceuticals is further developing currently marketed products in order to improve their application and/or extend the range of indications.

Pipeline overview

Here you can find an overview on our development pipeline. more

The following table sets forth our development projects including the respective indication, therapeutic area and development status. Click on Phase I to III to learn more about our pipeline.


Research and Development

More information about the topic Research and Development:

Contact Research Form

Page tools
.
Interactive tool
Grants for Targets
Annual Report 2013
Clinical Trials

open
close
http://www.bayerpharma.com/en/research-and-development/development-pipeline/index.php

Copyright © Bayer Pharma AG